-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Calumet, Raises Price Target to $60

Benzinga·03/30/2026 10:20:25
Listen to the news
HC Wainwright & Co. analyst Amit Dayal maintains Calumet (NASDAQ:CLMT) with a Buy and raises the price target from $33 to $60.